| TUPEB11 | Cause of death among infants by HIV status in Zambia, 2020-2021 | Poster exhibition | Antiretroviral therapies and clinical issues in infants, children and adolescents |
| TUPEB12 | Increased dolutegravir coverage is associated with increase in viral load coverage and suppression among children living with HIV in Togo | Poster exhibition | Antiretroviral therapies and clinical issues in infants, children and adolescents |
| TUPEB13 | Use of second-generation INSTIs in the treatment of children and adolescents in Mexico. A real-life national experience | Poster exhibition | Antiretroviral therapies and clinical issues in infants, children and adolescents |
| EPB0204 | Incidence of infections across Islatravir clinical development programs | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0205 | The relationship between gender-affirming hormone therapy and tenofovir dried blood spot concentrations among transgender adults switching from tenofovir disoproxil fumarate/emtricitabine to tenofovir alafenamide/emtricitabine for pre-exposure prophylaxis | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0206 | HIV treatment outcomes after 10 years on ART in the TREAT Asia Observational Database (TAHOD) and Australian HIV Observational Database (AHOD) | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0207 | Adverse pregnancy outcomes following dolutegravir transition among women delivering at surveillance sites in Eswatini | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0208 | Effect on weight changes upon discontinuation of dolutegravir from antiretroviral regimens among persons with HIV who experienced weight gain | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0209 | Real-world observational study in Europe on the effectiveness and safety of two-drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor (COMBINE-2): week 96 stable switch population results | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0210 | Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide fixed-dose combination for the treatment of people living with HIV in Argentina: first interim report of the BICTARG cohort | E-poster | Antiretroviral therapies and clinical issues in adults |